Reexpression of thyroid peroxidase in a derivative of an undifferentiated thyroid carcinoma cell line by introduction of wild-type p53

Cancer Research

Volumn 56, Issue 4, 1996, Pages 765-771

  Fagin, James A ^a,d   Tang, Shih Huey ^a   Zeki, Kazuya ^a   Di Lauro, Roberto ^b   Fusco, Alfredo ^c   Gonsky, Rivkah ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STAZIONE ZOOLOGICA ANTON DOHRN   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID PEROXIDASE;

ARTICLE; CARCINOMA CELL; CELL DEATH; CELL DIFFERENTIATION; COLONY FORMATION; GENE EXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; ONCOGENE RAS; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; THYROID CARCINOMA; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CELL ADHESION; CELL DIVISION; CELL LINE; DNA PRIMERS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; IODIDE PEROXIDASE; LUCIFERASES; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NUCLEAR PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RNA, NEOPLASM; THYROID NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030047639     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Hurlimann, J , Gardiol, D , and Scazziga, B. Immunohistology of anaplastic thyroid carcinoma. a study of 43 cases. Histopathology, 11: 567-580, 1987.
2. Schlumberger, M , Tubiana, M., De Vathaire, F., Hill, C., Gardet, P., Travagli, J-P., Fragu, P., Lumbroso, J , Caillou, B , and Parmentier, C. Long-term I results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab , 63: 960-967, 1986.
3. Ito, T., T. Seyama, T Mizuno, N. Tsuyama, T. Hayashi, Y Hayashi, D, Dohi, N. Nakamura, and M. Akiyama. Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res., 52: 1369-1372, 1992.
4. Fagin, J. A., Matsuo, K., Karmakar, A , Chen, D. L , Tang, S-H., and Koeffler, H. P. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest , 91 179-184, 1993
5. Dobashi, Y , Sakamoto, A., Sugimura, H., Mernyei, M , Mori, M., Oyama, T., and Machinami, R Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J. Surg Pathol., 17: 375-381, 1993.
6. Donghi, R , Longoni, A , Pilotti, S., Michieli, P., Della Porta, G , and Pierotti, M. A. p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J. Clin. Invest , 91: 1753-1760, 1993
7. Nakamura, T., Yana, I , Kobayashi, T , Shin, E., Karakawa, K , Fujita, S., Miya, A., Mori, T , Nishisho, I., and Takai, S. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas. Jpn. J. Cancer Res., 83: 1293-1298, 1992.
8. Raycroft, L., Hongyun, W., and Guillermina, L. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (Washington DC), 249: 1049-1051, 1990.
9. Kern, S E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. Identification of p53 as a sequence-specific DNA-binding protein. Science (Washington DC), 252: 1708-1711, 1991
10. Fields, S., and Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science (Washington DC), 249: 1046-1049, 1990.
11. Mack, D. H., Vartikar, J., Pipas, J. M , and Laimins, L. A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature (Lond.), 363: 281-283, 1993.
12. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M , Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
13. Mercer, W. E., Shields, E. M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that constitutionally expresses human wild-type p53. Proc. Natl. Acad. Sci USA, 87: 6166-6170, 1990.
14. Yonish-Rouach, E., Resnitsky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352. 345-347, 1991.
15. Namba, H., Gutman, R. A., Matsuo, K , Alvarez, A., and Fagin, J. A. H-ras protooncogene mutations in human thyroid neoplasms. J. Clin. Endocrinol. Metab., 71: 223-229, 1990
16. Lemoine, N. R., Mayall, E. S., Wyllie, F. S., Williams, E. D., Goyns, M., Stringer, B., and Wynford-Thomas, D High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene, 4: 159-164, 1989.
17. Namba, H., Rubin, S. A., and Fagin, J. A. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis. Mol. Endocrinol , 4: 1474-1479, 1990.
18. Suarez, H. G., du Villard, J. A., Severino, M., Caillou, B., Schlumberger, M., Tubiana, M., Parmentier, C., and Monier, R. Presence of mutations in all three ras genes in human thyroid tumors. Oncogenes, 5: 565-570, 1990.
19. Wani, M. A., Xu, X., and Stanbrook, P. J. Increased methotrexate resistance and DHFR gene amplification as a consequence of induced Ha-ras expression in NIH 3T3 cells. Cancer Res., 54: 2504-2508, 1994.
20. Finley, R. E., and Bishop, J M. Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science (Washington DC), 260: 1524-1527, 1993.
21. Francis-Lang, H., Zannini, M., De Felice, M., Berlingieri, M. T., Fusco, A., and Di Lauro, R Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol. Cell. Biol., 12: 5793-5800, 1992.
22. Estour, B., Van Herle, A. J., Juillard, G. J. F , Totanes, T. L., Sparkes, R S., Juliano, A. E., and Klandorf, H. Characterization of a human follicular carcinoma cell line. Virchows Archiv. B Cell Pathol., 57: 167-174, 1989.
23. Matsuo, K., Tang, S-H., Sharifi, B., Rubin, S. A , Schreck, R., and Fagin, J. A. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line. J. Clin. Endocrinol. Metab., 77: 996-1004, 1993
24. Baker, S. J., Markowitz, S , Fearon, E. R., Willson, J. K. V., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
25. Davis, L. G., Dibner, M. D., and Battey, J. F. Basic Methods in Molecular Biology, p. 1035. New York: Elsevier, 1986.
26. Zannini, M , Francis-Lang, H., Plachov, D., and Di Lauro, R. Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol. Cell. Biol , 12. 4230-4241, 1992.
27. Civitareale, D., Lonigro, R., Sinclair, A. J., and DiLauro, R. A thyroid specific nuclear protein essential for tissue specific expression of the thyroglobulin promoter. EMBO J., 8: 2573-2542, 1989.
28. Libert, F., Ruel, J , Ludgate, M., Swillens, S., Alexander, N., Vassart, G., and Dinsart, C. Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules EMBO J., 6: 4193-4196, 1987
29. Danielson, P. E., Forse-Petter, S , Brow, M. A., Calarett, L. L., Douglass, J., Milner, R J., and Sutcliff, J. G. A cDNA clone of the rat mRNA encoding cyclophylin. DNA, 7: 261-267, 1988.
30. Portmann, L., Fitch, F., Havran, W., Hamada, N., Franklin, W. A., and De Groot, L N Characterization of the thyroid microsomal antigen, and its relationship to thyroid peroxidase, using monoclonal antibodies. J Clin. Invest., 81: 1217-1224, 1988.
31. Francis-Lang, H., Price, M., Polycarpou-Schwarz, M , and Di Lauro, R. Cell-type specific expression of the rat thyroperoridase promoter indicates common mechanisms for thyroid-specific gene expression Mol. Cell. Biol., 12. 576-588, 1992.
32. Breslow, R , Jursic, B , Yan, Z. F., Friedman, E., Leng, L., Ngo, L., Rifkind, R. A., and Marks, P. A. Potent cylodifferentiating agents related to hexamethylenebisacetamide. Proc. Natl. Acad Sci. USA, 88: 5542-5546, 1991
33. Fagin, J. A. Molecular pathogenesis of human thyroid neoplasms. Thyroid Today XVII, 3: 1-7, 1994.
34. Lazzaro, D., Price, M., De Felice, M., and Di Lauro, R. The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development (Camb.), 12: 113-1104, 1991.
35. Avvedimento, V E , Musti, A. M., Ueffing, M., Obici, S., Gallo, A., Sanchez, M., De Brasi, D , and Gottesman, M. E. Reversible inhibition of a thyroid-specific transcription factor by ras. Genes & Dev , 5: 22-28, 1991.
36. Zhou, M., Shi, Y., and Farid, N. R. p53 mutations in all stages of thyroid carcinomas. J. Clin. Endocrinol. Metab., 77: 1054-1058, 1993.
37. Wright, P. A , Lemoine, N. R , Goretzki, P E., Wyllie, F. S , Bond, J., Hughes, C., Roher, H D , Williams, E. D , and Wynford-Thomas, D. Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene, 61: 1693-1697, 1991.
38. Chen, P-L., Bookstein, R., and Lee, W-H. Genetic mechanisms of rumor suppression by the human p53 gene. Science (Washington DC), 250: 1576-1580, 1990.
39. Lin, D., Fischella, M., O'Connor, P. M., Jackman, J., Chen, M., Luo, L L., Sala, A., Travali, S., Appella, E., and Mercer, W. E. Constitutive expression of B-myb can bypass p53-induced Waf1/mediated 1 arrest. Proc Natl. Acad. Sci. USA, 91: 10079-10083, 1994.
40. Kozmik, K , Kurzbauer, R., Dorfler, P., and Busslinger, M. Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties. Mol. Cell. Biol., 13: 6024-6035, 1993.
41. Battista, S., Martelli, M. L., Fedele, M., Chiappetta, G., Trapasso, F., De Vita, G., Battaglia, C., Santoro, M., Viglietto, G , Fagin, J. A., and Fusco, A. A mutated p53 alters thyroid cell differentiation. Oncogene, 11: 2029-2037, 1995.
42. Lane, D. P., and Crawford, L. V. T-antigen is bound to host protein in SV40-transformed cells. Nature (Lond), 278: 261-263, 1979.
43. Linzer, D. I., and Levine, A. J. Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40 transformed cells and in uninfected & embryonal cells Cell, 17: 43-52, 1979
44. Yew, P. R., and Berk, A. J. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (Lond.), 357: 82-85, 1992
45. Truant, R., Xiao, H , Ingles, C. J., and Greenblatt, J. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem., 268: 2284-2287, 1993
46. Lin, J , Chen, J., Elenbaas, B., and Levine, A. J. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus E1B 55-kD protein. Genes & Dev., 8: 1235-1246, 1994.
47. Livingstone, L. R , White, A , Sprouse, J , Livanos, E , Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
48. Pietenpol, J. A., Takino, T., Thiagalingam, S., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci USA, 92: 1998-2002, 1993.
49. Michalovitz, D., Halevy, O., and Oren, M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 Cell, 62: 671-680, 1990.
50. Martinez, J., Georgoff, I., Martinez, J., and Levine, A. J. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein Genes & Dev., 5: 151-159, 1991.
51. Donehower, L., Donehower, L. A., Harvey, M , Slagle, B. L , McArthur, M. J , Montgomery, C. A., Jr., Butel, J. S., and Bradley, A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature (Lond.), 356: 215-220, 1992.
52. Feinstein, E., Gale, R. P , Reed, J , and Canaani, E. Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene. 7: 1853-1857, 1992.
53. Soddu, S., Blandino, E., Citro, G., Scardigli, R., Piaggio, G., Ferber, A , Calabretta, B., and Scicchi, A. Wild-type p53 gene expression induces granulocytic differentiation of HL60 cells. Blood, 83 2230-2237, 1994.
54. Grieco, M., Santoro, M., Berlingieri, M T., Melillo, R. M., Donghi, R., Bongarzone, I., Pierotti, M. A., Della Porta, P. G., Fusco, A., and Vecchio, G PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas Cell, 60: 557-563, 1990.
55. Matsuo, K., Tang, S H., and Fagin, J A. Allelotype of human thyroid tumors: loss of chromosome 11q13 sequences in follicular neoplasms. Mol Endocrinol , 5: 1873-1879, 1991.
56. Herrmann, M. A., Hay, I. D., Bartelt, D. H., Jr., Ritland, S. R., Dahl, R. J., Grant, C. S., and Jenkins, R. B Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J. Clin. Invest , 88. 1596-1604, 1991.
57. Matsuo, K., Tang, S-H., Gutman, R. A., and Fagin, J. A Aberrant deoxyribonucleic acid methylation in human thyroid tumors J Clin Endocrinol. Metab., 77: 991-995, 1993.